Excellos logo

Excellos

A unique full-service CDMO, setting new standards in Cell & Gene Therapy

38 employees · est. 2021 · San Diego, United States

VS
Kincell Bio logo

Kincell Bio

Your CDMO Partner from Clinical to Commercial

94 employees · est. 2023 · Durham, United States

Excellos is the older company (2021 vs 2023); Kincell Bio is the larger of the two.

Side-by-Side Comparison

Excellos Kincell Bio
Founded
2021 older 2023
Headquarters
San Diego, United States Durham, United States
Employees
38 94 larger
Industry
Biotechnology, Health Care, Life Sciences Biopharma, Biotechnology, Pharmaceutical
Funding Stage
Corporate Round Unknown
Total Funding
$20.00M $58.00M
Funding Rounds
3 2
Services
Not tracked yet CMC Roadmap & Development, Analytical Development & Methods, Characterization & Release Testing, Early & Late Phase Process Development, Clinical & Commercial GMP Manufacturing, Tech Transfer In Playbook
Target Customers
Not tracked yet Biotechnology Companies, Cell Therapy Developers, Pharmaceutical Companies, Research Institutions
Taxonomy
Cell And Gene Therapy, CDMO, CGMP Manufacturing, TIL Therapies, CAR-T Therapy, Immunotherapy, Clinical Manufacturing, Life Science Research, Human Cell And Tissue Collection, Process Development, Global Scale Operations, Donor Pool Access, San Diego Blood Bank, Institutional Expertise Cell Therapy CDMO, Autologous Cell Therapies, Allogeneic Cell Therapies, Clinical Manufacturing, Commercial Manufacturing, CMC Strategies, GMP-compliant Manufacturing, Process Development, Analytical Development, Assay Optimization, Inspection Readiness, CAR-T Therapies, CAR-M Therapies, CAR-NK Therapies, TCR-T Therapies
Website
excellos.com kincellbio.com
Excellos logo

About Excellos

Excellos is a biotechnology startup based in the United States, founded in 2021. It operates as a unique full-service CDMO, focusing on cell and gene therapy innovation. Leveraging the expertise and resources of the San Diego Blood Bank with over 70 years of experience, Excellos aims to set a new in...

Kincell Bio logo

About Kincell Bio

Kincell Bio, founded in 2023, operates as a specialized cell therapy CDMO in the Biopharma, Biotechnology, and Pharmaceutical industries, with headquarters in the United States. Their slogan, Your CDMO Partner from Clinical to Commercial, encapsulates their mission of supporting autologous and allog...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Excellos and Kincell Bio — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Excellos and Kincell Bio — by email.

Frequently Asked Questions

Excellos — A unique full-service CDMO, setting new standards in Cell & Gene Therapy. Kincell Bio — Your CDMO Partner from Clinical to Commercial . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Excellos has raised $20.00M while Kincell Bio has raised $58.00M.
Excellos and Kincell Bio operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Excellos with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy